Huadong Medicine Co., Ltd (SHE:000963)

China flag China · Delayed Price · Currency is CNY
44.70
+1.34 (3.09%)
May 30, 2025, 3:04 PM CST
42.67%
Market Cap 78.22B
Revenue (ttm) 42.23B
Net Income (ttm) 3.56B
Shares Out 1.75B
EPS (ttm) 2.03
PE Ratio 22.00
Forward PE 18.28
Dividend 1.16 (2.60%)
Ex-Dividend Date Jun 5, 2025
Volume 23,408,081
Average Volume 15,561,296
Open 42.50
Previous Close 43.36
Day's Range 42.50 - 45.30
52-Week Range 25.96 - 45.11
Beta 0.55
RSI 72.58
Earnings Date May 14, 2025

About Huadong Medicine

Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. It operates through Pharmaceutical Industry, Pharmaceutical Business, Aesthetic Medicine, and Industrial Microbiology segments. The company distributes Chinese and western medicines, Chinese herbal medicines, and medical instruments; and immunosuppressive agents, endocrine drugs, digestive system drugs, antineoplastic drugs, cardiovascular drugs, antibiotic drugs, medical beauty field products, ... [Read more]

Sector Healthcare
Founded 1993
Employees 18,265
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000963
Full Company Profile

Financial Performance

In 2024, Huadong Medicine's revenue was 41.91 billion, an increase of 3.16% compared to the previous year's 40.62 billion. Earnings were 3.51 billion, an increase of 23.72%.

Financial Statements

News

There is no news available yet.